Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS accountability debate ‘lacks clarity’

April 17, 2008

A leading thinktank has criticised what it calls a lack of clarity in the debate over accountability in the NHS. …

News

AZ settles with generic challenger to Nexium

April 17, 2008
Sales and Marketing

AstraZeneca has settled its legal battle with Indian generics company Ranbaxy Laboratories over the US patents on Nexium, AstraZeneca's biggest …

News

Shire plans tax move to Ireland

April 17, 2008
Sales and Marketing

One of the UK's leading pharmaceutical companies is to shift its tax base to the Republic of Ireland to benefit …

News

Roche to buy Piramed

April 15, 2008
Sales and Marketing MA, Piramed

 Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …

News

Olympian projects require world-class planning

April 14, 2008
Research and Development clinical trials, project planning

The latest edition of the CMR International R&D Factbook shows that the mean time from protocol approval to final report …

Feature

Boehringer Ingelheim outpaces market

April 14, 2008
Sales and Marketing resp

Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …

News

NHS poll shows shortfall in care and hand washing

April 14, 2008

Less than half of NHS staff believes patient care is a top priority for trusts, according to a survey from …

News

Takeda buys up biotech Millennium

April 14, 2008
Sales and Marketing

Takeda has acquired US biotech company Millennium in an effort to boost its global presence in oncology. The Japanese firm …

News

Merck obesity drug to continue at low dose

April 11, 2008
Research and Development, Sales and Marketing

New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …

News

Study confers protective benefits on Micardis

April 4, 2008
Sales and Marketing cv

Boehringer Ingelheim's hypertension treatment Micardis has come out on top of Aventis's gold standard ACE inhibitor Tritace in a new …

News

UK clinical research is being transformed

April 4, 2008
Research and Development UK, clinical trials

Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …

Feature

Trial fails to enhance Inegy’s prospects

April 4, 2008
Sales and Marketing cv

Schering-Plough and Merck's much-touted anti-cholesterol combination Inegy has suffered a setback following a poor showing in the ENHANCE trial. Inegy …

News

Major leap in statin prescribing predicted

April 4, 2008
Sales and Marketing cv

News

Role of pharmacists to be extended

April 4, 2008

Pharmacists are to be given a greater role in patient treatment and promoting good health under new government plans. The …

News

Make Alzheimer’s a top research priority, says public

April 1, 2008

The British public wants a greater focus on research into Alzheimer's disease, according to an opinion poll conducted by the …

News

UCB’s Cimzia fails to appeal to European regulators

April 1, 2008
Sales and Marketing EU

UCB's Crohn's disease drug Cimzia has been denied European approval for a second time after regulators said lacked sufficient evidence …

News

Latest news from Datamonitor

March 31, 2008
Sales and Marketing

The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …

News

The role of audit in marketing excellence

March 28, 2008
Sales and Marketing audit, excellence, marketing

The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …

Feature

Gardasil licence extension gets priority FDA review

March 28, 2008
Sales and Marketing

Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …

News

Accomplia gains limited NICE approval

March 28, 2008
Sales and Marketing

Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026